Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	DNA-binding transcription factor activity, RNA polymerase II-specific	ATMIN ZBTB47 ZBTB8A ZNF76 DMRTA1 ZNF580 BCL6 ZNF768 ZNF785 ZNF774 ZNF764 NTN3	8.90e-07	1412	32	12	GO:0000981
GeneOntologyMolecularFunction	vascular endothelial growth factor receptor 3 binding	VEGFC VEGFD	2.49e-06	2	32	2	GO:0043185
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	ZBTB8A ZNF76 DMRTA1 ZNF580 BCL6 ZNF564 ZNF768 ZNF785 ZNF774 ZNF764 NTN3	9.37e-06	1459	32	11	GO:0000977
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	ZBTB8A ZNF76 DMRTA1 ZNF580 BCL6 ZNF564 ZNF768 ZNF774 ZNF764 NTN3	1.55e-05	1244	32	10	GO:0000978
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	ZBTB8A ZNF76 DMRTA1 ZNF580 BCL6 ZNF564 ZNF768 ZNF774 ZNF764 NTN3	1.87e-05	1271	32	10	GO:0000987
GeneOntologyMolecularFunction	vascular endothelial growth factor receptor binding	VEGFC VEGFD	3.33e-04	17	32	2	GO:0005172
GeneOntologyMolecularFunction	extracellular matrix structural constituent	LAMA2 HMCN2 SSPOP	3.33e-03	188	32	3	GO:0005201
GeneOntologyMolecularFunction	chemoattractant activity	VEGFC VEGFD	3.38e-03	54	32	2	GO:0042056
GeneOntologyBiologicalProcess	positive regulation of endothelial cell proliferation	VEGFC ZNF580 TEK VEGFD	4.59e-05	125	33	4	GO:0001938
GeneOntologyBiologicalProcess	regulation of vascular endothelial growth factor receptor signaling pathway	VEGFC TEK VEGFD	4.73e-05	44	33	3	GO:0030947
GeneOntologyBiologicalProcess	positive regulation of mast cell chemotaxis	VEGFC VEGFD	5.19e-05	7	33	2	GO:0060754
GeneOntologyBiologicalProcess	regulation of mast cell chemotaxis	VEGFC VEGFD	8.87e-05	9	33	2	GO:0060753
GeneOntologyBiologicalProcess	cell-cell adhesion via plasma-membrane adhesion molecules	CELSR1 HMCN2 CELSR2 SCARF2 CRB2	1.31e-04	313	33	5	GO:0098742
GeneOntologyBiologicalProcess	vascular endothelial growth factor receptor signaling pathway	VEGFC TEK VEGFD	1.82e-04	69	33	3	GO:0048010
GeneOntologyBiologicalProcess	cell-cell adhesion	CELSR1 BCL6 HMCN2 CELSR2 TEK SCARF2 MEGF11 CRB2	2.32e-04	1077	33	8	GO:0098609
GeneOntologyBiologicalProcess	motor neuron migration	CELSR1 CELSR2	2.57e-04	15	33	2	GO:0097475
GeneOntologyBiologicalProcess	mast cell chemotaxis	VEGFC VEGFD	2.94e-04	16	33	2	GO:0002551
GeneOntologyBiologicalProcess	regulation of endothelial cell proliferation	VEGFC ZNF580 TEK VEGFD	3.27e-04	208	33	4	GO:0001936
GeneOntologyBiologicalProcess	induction of positive chemotaxis	VEGFC VEGFD	3.33e-04	17	33	2	GO:0050930
GeneOntologyBiologicalProcess	anatomical structure formation involved in morphogenesis	VEGFC CELSR1 BCL6 TEK VEGFD MEGF11 NTN3 CRB2 MYBPC3	3.98e-04	1483	33	9	GO:0048646
GeneOntologyBiologicalProcess	mast cell migration	VEGFC VEGFD	4.17e-04	19	33	2	GO:0097531
GeneOntologyBiologicalProcess	endothelial cell proliferation	VEGFC ZNF580 TEK VEGFD	5.18e-04	235	33	4	GO:0001935
GeneOntologyBiologicalProcess	anterior/posterior pattern specification	CELSR1 CELSR2 CRB2 WIF1	6.25e-04	247	33	4	GO:0009952
GeneOntologyBiologicalProcess	positive regulation of leukocyte chemotaxis	VEGFC ZNF580 VEGFD	6.98e-04	109	33	3	GO:0002690
GeneOntologyBiologicalProcess	animal organ morphogenesis	VEGFC LAMA2 CELSR1 TEK MEGF11 NTN3 CRB2 MYBPC3	6.99e-04	1269	33	8	GO:0009887
GeneOntologyBiologicalProcess	positive regulation of epithelial cell proliferation	VEGFC ZNF580 TEK VEGFD	8.71e-04	270	33	4	GO:0050679
GeneOntologyBiologicalProcess	positive regulation of positive chemotaxis	VEGFC VEGFD	9.81e-04	29	33	2	GO:0050927
GeneOntologyBiologicalProcess	regulation of positive chemotaxis	VEGFC VEGFD	1.05e-03	30	33	2	GO:0050926
GeneOntologyCellularComponent	extracellular matrix	ADAMTS10 LAMA2 FCGBP HMCN2 SSPOP NTN3	4.21e-04	656	32	6	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	ADAMTS10 LAMA2 FCGBP HMCN2 SSPOP NTN3	4.28e-04	658	32	6	GO:0030312
GeneOntologyCellularComponent	basement membrane	LAMA2 HMCN2 NTN3	8.50e-04	122	32	3	GO:0005604
GeneOntologyCellularComponent	collagen-containing extracellular matrix	ADAMTS10 LAMA2 HMCN2 SSPOP NTN3	1.18e-03	530	32	5	GO:0062023
HumanPheno	Edema	VEGFC LAMA2 CELSR1 BCL6 ARSL TEK CRB2 MYBPC3	4.22e-06	699	10	8	HP:0000969
HumanPheno	Abnormality of fluid regulation	VEGFC LAMA2 CELSR1 BCL6 ARSL TEK CRB2 MYBPC3	1.08e-05	789	10	8	HP:0011032
Domain	EGF_1	LAMA2 CELSR1 HMCN2 CELSR2 TEK SSPOP SCARF2 VWDE MEGF11 NTN3 CRB2 WIF1	8.91e-15	255	33	12	PS00022
Domain	EGF_2	LAMA2 CELSR1 HMCN2 CELSR2 TEK SSPOP SCARF2 VWDE MEGF11 NTN3 CRB2 WIF1	1.41e-14	265	33	12	PS01186
Domain	EGF-like_dom	LAMA2 CELSR1 FCGBP HMCN2 CELSR2 TEK SCARF2 VWDE MEGF11 CRB2 WIF1	2.83e-13	249	33	11	IPR000742
Domain	EGF-like_CS	LAMA2 CELSR1 HMCN2 CELSR2 TEK SCARF2 VWDE MEGF11 NTN3 CRB2 WIF1	4.74e-13	261	33	11	IPR013032
Domain	EGF_3	CELSR1 HMCN2 CELSR2 TEK SSPOP SCARF2 VWDE MEGF11 CRB2 WIF1	5.90e-12	235	33	10	PS50026
Domain	EGF	LAMA2 CELSR1 FCGBP CELSR2 TEK SCARF2 VWDE MEGF11 CRB2 WIF1	5.90e-12	235	33	10	SM00181
Domain	Laminin_EGF	LAMA2 CELSR1 CELSR2 SCARF2 MEGF11 NTN3	2.94e-11	35	33	6	PF00053
Domain	EGF_Lam	LAMA2 CELSR1 CELSR2 SCARF2 MEGF11 NTN3	2.94e-11	35	33	6	SM00180
Domain	Laminin_EGF	LAMA2 CELSR1 CELSR2 SCARF2 MEGF11 NTN3	4.99e-11	38	33	6	IPR002049
Domain	ZINC_FINGER_C2H2_2	ATMIN ZBTB47 ZBTB8A ZNF76 ZNF580 BCL6 ZNF564 ZNF768 ZNF785 ZNF774 ZNF764	4.90e-08	775	33	11	PS50157
Domain	ZINC_FINGER_C2H2_1	ATMIN ZBTB47 ZBTB8A ZNF76 ZNF580 BCL6 ZNF564 ZNF768 ZNF785 ZNF774 ZNF764	5.03e-08	777	33	11	PS00028
Domain	Znf_C2H2-like	ATMIN ZBTB47 ZBTB8A ZNF76 ZNF580 BCL6 ZNF564 ZNF768 ZNF785 ZNF774 ZNF764	6.44e-08	796	33	11	IPR015880
Domain	Znf_C2H2	ATMIN ZBTB47 ZBTB8A ZNF76 ZNF580 BCL6 ZNF564 ZNF768 ZNF785 ZNF774 ZNF764	7.22e-08	805	33	11	IPR007087
Domain	ZnF_C2H2	ATMIN ZBTB47 ZBTB8A ZNF76 ZNF580 BCL6 ZNF564 ZNF768 ZNF785 ZNF774 ZNF764	7.50e-08	808	33	11	SM00355
Domain	hEGF	CELSR2 MEGF11 CRB2 WIF1	1.60e-07	28	33	4	PF12661
Domain	-	ZBTB47 ZBTB8A ZNF76 ZNF580 BCL6 ZNF564 ZNF768 ZNF785 ZNF774 ZNF764	1.64e-07	679	33	10	3.30.160.60
Domain	zf-C2H2	ZBTB47 ZBTB8A ZNF76 ZNF580 BCL6 ZNF564 ZNF768 ZNF785 ZNF774 ZNF764	1.98e-07	693	33	10	PF00096
Domain	Znf_C2H2/integrase_DNA-bd	ZBTB47 ZBTB8A ZNF76 ZNF580 BCL6 ZNF564 ZNF768 ZNF785 ZNF774 ZNF764	2.01e-07	694	33	10	IPR013087
Domain	EGF_LAM_2	LAMA2 CELSR1 CELSR2 NTN3	2.14e-07	30	33	4	PS50027
Domain	EGF_LAM_1	LAMA2 CELSR1 CELSR2 NTN3	2.14e-07	30	33	4	PS01248
Domain	Growth_fac_rcpt_	CELSR1 HMCN2 CELSR2 TEK SCARF2 NTN3	2.83e-07	156	33	6	IPR009030
Domain	LAM_G_DOMAIN	LAMA2 CELSR1 CELSR2 CRB2	5.71e-07	38	33	4	PS50025
Domain	Laminin_G_2	LAMA2 CELSR1 CELSR2 CRB2	7.06e-07	40	33	4	PF02210
Domain	LamG	LAMA2 CELSR1 CELSR2 CRB2	1.04e-06	44	33	4	SM00282
Domain	VWFD	FCGBP SSPOP VWDE	2.77e-06	16	33	3	PS51233
Domain	VWD	FCGBP SSPOP VWDE	2.77e-06	16	33	3	SM00216
Domain	VWF_type-D	FCGBP SSPOP VWDE	2.77e-06	16	33	3	IPR001846
Domain	VWD	FCGBP SSPOP VWDE	2.77e-06	16	33	3	PF00094
Domain	CXCXC_repeat	VEGFC VEGFD	3.03e-06	2	33	2	IPR004153
Domain	CXCXC	VEGFC VEGFD	3.03e-06	2	33	2	PF03128
Domain	Laminin_G	LAMA2 CELSR1 CELSR2 CRB2	3.20e-06	58	33	4	IPR001791
Domain	EGF_extracell	TEK SCARF2 MEGF11 WIF1	3.67e-06	60	33	4	IPR013111
Domain	EGF_2	TEK SCARF2 MEGF11 WIF1	3.67e-06	60	33	4	PF07974
Domain	-	LAMA2 CELSR1 CELSR2 CRB2	2.30e-05	95	33	4	2.60.120.200
Domain	ASX_HYDROXYL	CELSR1 HMCN2 CELSR2 CRB2	2.81e-05	100	33	4	PS00010
Domain	EGF-type_Asp/Asn_hydroxyl_site	CELSR1 HMCN2 CELSR2 CRB2	3.53e-05	106	33	4	IPR000152
Domain	EGF_CA	CELSR1 HMCN2 CELSR2 CRB2	6.12e-05	122	33	4	SM00179
Domain	PD_growth_factor_CS	VEGFC VEGFD	6.32e-05	7	33	2	IPR023581
Domain	EGF-like_Ca-bd_dom	CELSR1 HMCN2 CELSR2 CRB2	6.52e-05	124	33	4	IPR001881
Domain	EGF	CELSR1 CELSR2 CRB2 WIF1	6.94e-05	126	33	4	PF00008
Domain	PDGF_2	VEGFC VEGFD	1.08e-04	9	33	2	PS50278
Domain	PDGF_1	VEGFC VEGFD	1.08e-04	9	33	2	PS00249
Domain	PDGF/VEGF_dom	VEGFC VEGFD	1.08e-04	9	33	2	IPR000072
Domain	PDGF	VEGFC VEGFD	1.08e-04	9	33	2	PF00341
Domain	PDGF	VEGFC VEGFD	1.08e-04	9	33	2	SM00141
Domain	GAIN_dom_N	CELSR1 CELSR2	1.65e-04	11	33	2	IPR032471
Domain	GAIN	CELSR1 CELSR2	1.65e-04	11	33	2	PF16489
Domain	TIL	FCGBP SSPOP	1.98e-04	12	33	2	PF01826
Domain	C8	FCGBP SSPOP	1.98e-04	12	33	2	PF08742
Domain	Unchr_dom_Cys-rich	FCGBP SSPOP	2.33e-04	13	33	2	IPR014853
Domain	C8	FCGBP SSPOP	2.33e-04	13	33	2	SM00832
Domain	TIL_dom	FCGBP SSPOP	2.72e-04	14	33	2	IPR002919
Domain	LAMININ_NTER	LAMA2 NTN3	3.58e-04	16	33	2	PS51117
Domain	Laminin_N	LAMA2 NTN3	3.58e-04	16	33	2	PF00055
Domain	Laminin_N	LAMA2 NTN3	3.58e-04	16	33	2	IPR008211
Domain	LamNT	LAMA2 NTN3	3.58e-04	16	33	2	SM00136
Domain	KRAB	ZNF747 ZNF564 ZNF785 ZNF774 ZNF764	3.84e-04	358	33	5	PS50805
Domain	EMI	SSPOP MEGF11	4.05e-04	17	33	2	PS51041
Domain	VWC_out	FCGBP SSPOP	5.08e-04	19	33	2	SM00215
Domain	ConA-like_dom	LAMA2 CELSR1 CELSR2 CRB2	5.76e-04	219	33	4	IPR013320
Domain	Galactose-bd-like	LAMA2 SSPOP NTN3	6.04e-04	94	33	3	IPR008979
Domain	HormR	CELSR1 CELSR2	8.85e-04	25	33	2	SM00008
Domain	TNFR	TNFRSF25 CELSR2	9.58e-04	26	33	2	SM00208
Domain	HRM	CELSR1 CELSR2	1.11e-03	28	33	2	PF02793
Domain	TNFR/NGFR_Cys_rich_reg	TNFRSF25 CELSR2	1.54e-03	33	33	2	IPR001368
Domain	BTB	ZBTB47 ZBTB8A BCL6	1.58e-03	131	33	3	PF00651
Domain	GPS	CELSR1 CELSR2	1.64e-03	34	33	2	SM00303
Domain	GPS	CELSR1 CELSR2	1.74e-03	35	33	2	PF01825
Domain	GPS	CELSR1 CELSR2	1.84e-03	36	33	2	PS50221
Domain	GPS	CELSR1 CELSR2	1.94e-03	37	33	2	IPR000203
Domain	VWC	FCGBP SSPOP	2.05e-03	38	33	2	SM00214
Domain	G_PROTEIN_RECEP_F2_1	CELSR1 CELSR2	2.26e-03	40	33	2	PS00649
Domain	G_PROTEIN_RECEP_F2_3	CELSR1 CELSR2	2.26e-03	40	33	2	PS50227
Domain	GPCR_2_extracellular_dom	CELSR1 CELSR2	2.26e-03	40	33	2	IPR001879
Domain	VWF_dom	FCGBP SSPOP	2.49e-03	42	33	2	IPR001007
Domain	BTB	ZBTB47 ZBTB8A BCL6	2.79e-03	160	33	3	PS50097
Domain	KRAB	ZNF747 ZNF564 ZNF785 ZNF764	3.50e-03	358	33	4	PF01352
Domain	G_PROTEIN_RECEP_F2_2	CELSR1 CELSR2	3.52e-03	50	33	2	PS00650
Domain	7tm_2	CELSR1 CELSR2	3.52e-03	50	33	2	PF00002
Domain	BTB	ZBTB47 ZBTB8A BCL6	3.88e-03	180	33	3	SM00225
Domain	KRAB	ZNF747 ZNF564 ZNF785 ZNF764	3.90e-03	369	33	4	SM00349
Domain	KRAB	ZNF747 ZNF564 ZNF785 ZNF764	3.94e-03	370	33	4	IPR001909
Domain	BTB/POZ_dom	ZBTB47 ZBTB8A BCL6	4.19e-03	185	33	3	IPR000210
Domain	SKP1/BTB/POZ	ZBTB47 ZBTB8A BCL6	4.45e-03	189	33	3	IPR011333
Domain	GPCR_2-like	CELSR1 CELSR2	5.03e-03	60	33	2	IPR017981
Domain	GPCR_2_secretin-like	CELSR1 CELSR2	5.03e-03	60	33	2	IPR000832
Pathway	REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS	VEGFC VEGFD	7.09e-05	8	23	2	M710
Pathway	REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS	VEGFC VEGFD	7.09e-05	8	23	2	MM14753
Pathway	PID_VEGF_VEGFR_PATHWAY	VEGFC VEGFD	1.14e-04	10	23	2	M137
Pathway	KEGG_MEDICUS_REFERENCE_GF_RTK_PI3K_SIGNALING_PATHWAY	VEGFC TEK VEGFD	3.20e-04	83	23	3	M47961
Pathway	KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_PI3K_SIGNALING_PATHWAY	VEGFC TEK VEGFD	3.93e-04	89	23	3	M47963
Pathway	KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_ERK_SIGNALING_PATHWAY	VEGFC TEK VEGFD	4.33e-04	92	23	3	M47927
Pathway	WP_PLEURAL_MESOTHELIOMA	VEGFC LAMA2 TEK VEGFD WIF1	6.05e-04	439	23	5	M42563
Pathway	PID_LYMPH_ANGIOGENESIS_PATHWAY	VEGFC VEGFD	7.47e-04	25	23	2	M274
Pathway	PID_INTEGRIN_A9B1_PATHWAY	VEGFC VEGFD	7.47e-04	25	23	2	M118
Pathway	WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING	VEGFC LAMA2 TEK VEGFD	1.33e-03	302	23	4	M39719
Pathway	WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY	VEGFC LAMA2 TEK VEGFD	1.76e-03	326	23	4	MM15917
Pathway	WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER	VEGFC VEGFD	1.82e-03	39	23	2	M46456
Pathway	REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS	ADAMTS10 SSPOP	1.82e-03	39	23	2	MM15165
Pathway	REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS	ADAMTS10 SSPOP	1.82e-03	39	23	2	M27417
Pathway	WP_PI3KAKT_SIGNALING	VEGFC LAMA2 TEK VEGFD	2.03e-03	339	23	4	M39736
Pathway	KEGG_BLADDER_CANCER	VEGFC VEGFD	2.11e-03	42	23	2	M19096
Pathway	PID_PS1_PATHWAY	SSPOP WIF1	2.52e-03	46	23	2	M70
Pathway	WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER	VEGFC VEGFD	2.52e-03	46	23	2	M46466
Pathway	KEGG_MTOR_SIGNALING_PATHWAY	VEGFC VEGFD	3.21e-03	52	23	2	M7561
Pathway	WP_FOCAL_ADHESION	VEGFC LAMA2 VEGFD	3.35e-03	187	23	3	MM15913
Pathway	KEGG_MEDICUS_REFERENCE_RTK_PLCG_ITPR_SIGNALING_PATHWAY	VEGFC VEGFD	3.59e-03	55	23	2	M47952
Pathway	WP_FOCAL_ADHESION	VEGFC LAMA2 VEGFD	3.98e-03	199	23	3	M39402
Pathway	KEGG_FOCAL_ADHESION	VEGFC LAMA2 VEGFD	3.98e-03	199	23	3	M7253
Pathway	REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS	ADAMTS10 SSPOP	5.43e-03	68	23	2	M27303
Pathway	KEGG_RENAL_CELL_CARCINOMA	VEGFC VEGFD	5.75e-03	70	23	2	M13266
Pathway	KEGG_PANCREATIC_CANCER	VEGFC VEGFD	5.75e-03	70	23	2	M9726
Pubmed	Genome-wide characterization of Foxa2 targets reveals upregulation of floor plate genes and repression of ventrolateral genes in midbrain dopaminergic progenitors.	VEGFC LAMA2 DMRTA1 BCL6	9.73e-08	45	33	4	22696295
Pubmed	Lack of cadherins Celsr2 and Celsr3 impairs ependymal ciliogenesis, leading to fatal hydrocephalus.	CELSR1 CELSR2 SSPOP	3.51e-07	15	33	3	20473291
Pubmed	Lymphangiogenesis induced by VEGF-C and VEGF-D promotes metastasis and a poor outcome in breast carcinoma: a retrospective study of 61 cases.	VEGFC VEGFD	8.73e-07	2	33	2	18512120
Pubmed	[Expression and clinical significance of vascular endothelial growth factor C and D in nasopharyngeal carcinoma].	VEGFC VEGFD	8.73e-07	2	33	2	17222375
Pubmed	[Expressions of VEGF-C and VEGF-D and their correlation with lymphangiogenesis and angiogenesis in gallbladder carcinoma].	VEGFC VEGFD	8.73e-07	2	33	2	20450586
Pubmed	Characterization of indolinones which preferentially inhibit VEGF-C- and VEGF-D-induced activation of VEGFR-3 rather than VEGFR-2.	VEGFC VEGFD	8.73e-07	2	33	2	11683876
Pubmed	Predictive significance of preoperative serum VEGF-C and VEGF-D, independently and combined with Ca19-9, for the presence of malignancy and lymph node metastasis in patients with gastric cancer.	VEGFC VEGFD	8.73e-07	2	33	2	20672317
Pubmed	The role of VEGF-C/D and Flt-4 in the lymphatic metastasis of early-stage invasive cervical carcinoma.	VEGFC VEGFD	8.73e-07	2	33	2	19589137
Pubmed	[Expression and significance of VEGF-C and VEGF-D in differentiated thyroid carcinoma].	VEGFC VEGFD	8.73e-07	2	33	2	19771906
Pubmed	VEGF-C and VEGF-D expression and its correlation with lymph node metastasis in esophageal squamous cell cancer tissue.	VEGFC VEGFD	8.73e-07	2	33	2	25640364
Pubmed	Vascular endothelial growth factors C and D induces proliferation of lymphangioleiomyomatosis cells through autocrine crosstalk with endothelium.	VEGFC VEGFD	8.73e-07	2	33	2	19717640
Pubmed	Vascular endothelial growth factor-C and -D expression correlates with lymph node micrometastasis in pN0 early gastric cancer.	VEGFC VEGFD	8.73e-07	2	33	2	19117016
Pubmed	Serum vascular endothelial growth factors C and D as forecast tools for patients with gallbladder carcinoma.	VEGFC VEGFD	8.73e-07	2	33	2	25801241
Pubmed	Correlation between lymph node metastasis and the expression of VEGF-C, VEGF-D and VEGFR-3 in T1 lung adenocarcinoma.	VEGFC VEGFD	8.73e-07	2	33	2	17970036
Pubmed	VEGF-C and VEGF-D overexpression is more common in left-sided and well-differentiated colon adenocarcinoma.	VEGFC VEGFD	8.73e-07	2	33	2	24173916
Pubmed	Expression of vascular endothelial growth factors-C and -D correlate with evidence of lymphangiogenesis and angiogenesis in pancreatic adenocarcinoma.	VEGFC VEGFD	8.73e-07	2	33	2	18061373
Pubmed	Lymphatic microvessel density and vascular endothelial growth factor-C and -D as prognostic factors in breast cancer: a systematic review and meta-analysis of the literature.	VEGFC VEGFD	8.73e-07	2	33	2	23054001
Pubmed	Peritumoral lymphangiogenesis induced by vascular endothelial growth factor C and D promotes lymph node metastasis in breast cancer patients.	VEGFC VEGFD	8.73e-07	2	33	2	22906075
Pubmed	Role of vascular endothelial growth factor-C and -D mRNA in breast cancer.	VEGFC VEGFD	8.73e-07	2	33	2	18717190
Pubmed	Lymphatic vessel density, microvessel density and lymphangiogenic growth factor expression in colorectal cancer.	VEGFC VEGFD	8.73e-07	2	33	2	17931169
Pubmed	[Lymphangiogenesis axis in bladder carcinoma. An analysis with tissue microarray technology].	VEGFC VEGFD	8.73e-07	2	33	2	17676294
Pubmed	Vascular endothelial growth factor C and D expression correlates with lymph node metastasis and poor prognosis in patients with resected esophageal cancer.	VEGFC VEGFD	8.73e-07	2	33	2	21520987
Pubmed	Expression of VEGF-C/-D and lymphangiogenesis in salivary adenoid cystic carcinoma.	VEGFC VEGFD	8.73e-07	2	33	2	26296919
Pubmed	Vascular endothelial growth factor-C and -D are involved in lymphangiogenesis in mouse unilateral ureteral obstruction.	VEGFC VEGFD	8.73e-07	2	33	2	22932121
Pubmed	Expression of vascular endothelial growth factors C and D correlates with lymphangiogenesis and lymph node metastasis in lung adenocarcinoma.	VEGFC VEGFD	8.73e-07	2	33	2	19629892
Pubmed	Differential Receptor Binding and Regulatory Mechanisms for the Lymphangiogenic Growth Factors Vascular Endothelial Growth Factor (VEGF)-C and -D.	VEGFC VEGFD	8.73e-07	2	33	2	27852824
Pubmed	Distinct Characteristics of VEGF-D and VEGF-C to Predict Mortality in Patients With Suspected or Known Coronary Artery Disease.	VEGFC VEGFD	8.73e-07	2	33	2	32319336
Pubmed	Significance of Vascular Endothelial Growth Factor (VEGF)-C and VEGF-D in the Progression of Cutaneous Melanoma.	VEGFC VEGFD	8.73e-07	2	33	2	25911567
Pubmed	Localisation of lymphatic vessels and vascular endothelial growth factors-C and -D in human and mouse skeletal muscle with immunohistochemistry.	VEGFC VEGFD	8.73e-07	2	33	2	16924525
Pubmed	Impact of vascular endothelial growth factor-C and -D expression in human pancreatic cancer: its relationship to lymph node metastasis.	VEGFC VEGFD	8.73e-07	2	33	2	15623620
Pubmed	[Relationship between clinicopathologic characteristics and expression of VEGF-C and VEGF-D in esophageal squamous cancer].	VEGFC VEGFD	8.73e-07	2	33	2	19462898
Pubmed	Activated forms of VEGF-C and VEGF-D provide improved vascular function in skeletal muscle.	VEGFC VEGFD	8.73e-07	2	33	2	19443835
Pubmed	VEGF-C and VEGF-D blockade inhibits inflammatory skin carcinogenesis.	VEGFC VEGFD	8.73e-07	2	33	2	23695550
Pubmed	Drosophila ATP6AP2/VhaPRR functions both as a novel planar cell polarity core protein and a regulator of endosomal trafficking.	CELSR1 CELSR2	8.73e-07	2	33	2	23292348
Pubmed	[Expression of VEGF-C and VEGF-D in gastric carcinoma and its relationship with lymph node metastases].	VEGFC VEGFD	8.73e-07	2	33	2	20448355
Pubmed	Macrophages define dermal lymphatic vessel calibre during development by regulating lymphatic endothelial cell proliferation.	VEGFC TEK VEGFD	1.99e-06	26	33	3	20978081
Pubmed	Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis.	VEGFC TEK VEGFD	2.51e-06	28	33	3	18593464
Pubmed	Functional interaction of VEGF-C and VEGF-D with neuropilin receptors.	VEGFC VEGFD	2.62e-06	3	33	2	16816121
Pubmed	Clinical significance of vascular endothelial growth factors C and D and chemokine receptor CCR7 in gastric cancer.	VEGFC VEGFD	2.62e-06	3	33	2	20651394
Pubmed	Expression of VEGF-C, VEGF-D and their receptor VEGFR-3 in diffuse large B-cell lymphomas.	VEGFC VEGFD	2.62e-06	3	33	2	17926187
Pubmed	Serum vascular endothelial growth factors a, C and d in human breast tumors.	VEGFC VEGFD	2.62e-06	3	33	2	19821158
Pubmed	SPARC suppresses lymph node metastasis by regulating the expression of VEGFs in ovarian carcinoma.	VEGFC VEGFD	2.62e-06	3	33	2	29075785
Pubmed	The role of the VEGF-C/-D/flt-4 autocrine loop in the pathogenesis of salivary neoplasms.	VEGFC VEGFD	2.62e-06	3	33	2	22326635
Pubmed	High interstitial fluid pressure promotes tumor progression through inducing lymphatic metastasis-related protein expressions in oral squamous cell carcinoma.	VEGFC VEGFD	2.62e-06	3	33	2	24085575
Pubmed	The flamingo-related mouse Celsr family (Celsr1-3) genes exhibit distinct patterns of expression during embryonic development.	CELSR1 CELSR2	2.62e-06	3	33	2	11677057
Pubmed	Effects of acute exercise, exercise training, and diabetes on the expression of lymphangiogenic growth factors and lymphatic vessels in skeletal muscle.	VEGFC VEGFD	2.62e-06	3	33	2	17766486
Pubmed	Vascular endothelial growth factor D is dispensable for development of the lymphatic system.	VEGFC VEGFD	2.62e-06	3	33	2	15743836
Pubmed	Soluble vascular endothelial growth factor receptor-3 suppresses lymphangiogenesis and lymphatic metastasis in bladder cancer.	VEGFC VEGFD	2.62e-06	3	33	2	21481239
Pubmed	Vascular endothelial growth factor (VEGF)-C, VEGF-D, VEGFR-3 and D2-40 expressions in primary breast cancer: Association with lymph node metastasis.	VEGFC VEGFD	2.62e-06	3	33	2	28791841
Pubmed	Lymphangiogenesis and angiogenesis in bladder cancer: prognostic implications and regulation by vascular endothelial growth factors-A, -C, and -D.	VEGFC VEGFD	2.62e-06	3	33	2	16467091
Pubmed	Plasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-D.	VEGFC VEGFD	2.62e-06	3	33	2	12963694
Pubmed	Hemostasis stimulates lymphangiogenesis through release and activation of VEGFC.	VEGFC VEGFD	2.62e-06	3	33	2	31562136
Pubmed	Effect of vascular endothelial growth factors A, C, and D in HIV-associated pre-eclampsia.	VEGFC VEGFD	2.62e-06	3	33	2	28524736
Pubmed	Dual role of VEGF family members in the pathogenesis of head and neck cancer (HNSCC): possible link between angiogenesis and immune tolerance.	VEGFC VEGFD	2.62e-06	3	33	2	16049374
Pubmed	Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.	VEGFC VEGFD	2.62e-06	3	33	2	18561194
Pubmed	Dosage-dependent requirement for mouse Vezf1 in vascular system development.	VEGFC TEK VEGFD	2.80e-06	29	33	3	15882861
Pubmed	Secondary Placental Defects in Cxadr Mutant Mice.	VEGFC TEK VEGFD	3.79e-06	32	33	3	31338035
Pubmed	IGFBP7 functions as a potential lymphangiogenesis inducer in non-small cell lung carcinoma.	VEGFC VEGFD	5.23e-06	4	33	2	26706909
Pubmed	Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution.	VEGFC VEGFD	5.23e-06	4	33	2	19346498
Pubmed	The adhesion GPCRs CELSR1-3 and LPHN3 engage G proteins via distinct activation mechanisms.	CELSR1 CELSR2	5.23e-06	4	33	2	37224017
Pubmed	Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation.	VEGFC VEGFD	5.23e-06	4	33	2	9684805
Pubmed	MTA1 Is Up-regulated in Colorectal Cancer and Is Inversely Correlated with Lymphatic Metastasis.	VEGFC VEGFD	5.23e-06	4	33	2	26543080
Pubmed	The lymphangiogenic vascular endothelial growth factors VEGF-C and -D are ligands for the integrin alpha9beta1.	VEGFC VEGFD	5.23e-06	4	33	2	15590642
Pubmed	Angiogenic/lymphangiogenic factors and adaptation to extreme altitudes during an expedition to Mount Everest.	VEGFC VEGFD	5.23e-06	4	33	2	18983460
Pubmed	Dysregulation of vascular endothelial growth factors and their neuropilin receptors in the eutopic endometrium of women with endometriosis.	VEGFC VEGFD	5.23e-06	4	33	2	23585340
Pubmed	Developmental expression profiles of Celsr (Flamingo) genes in the mouse.	CELSR1 CELSR2	5.23e-06	4	33	2	11850187
Pubmed	Association of CXCR4, CCR7, VEGF-C and VEGF-D expression with lymph node metastasis in patients with cervical cancer.	VEGFC VEGFD	5.23e-06	4	33	2	28535405
Pubmed	KLK3/PSA and cathepsin D activate VEGF-C and VEGF-D.	VEGFC VEGFD	5.23e-06	4	33	2	31099754
Pubmed	Vascular endothelial growth factors synthesized by human lung mast cells exert angiogenic effects.	VEGFC VEGFD	5.23e-06	4	33	2	19275959
Pubmed	Interleukin-8: A potent promoter of human lymphatic endothelial cell growth in gastric cancer.	VEGFC VEGFD	5.23e-06	4	33	2	25891418
Pubmed	Development and plasticity of meningeal lymphatic vessels.	VEGFC VEGFD	5.23e-06	4	33	2	29141865
Pubmed	Hemicentin-1 is an essential extracellular matrix component of the dermal-epidermal and myotendinous junctions.	LAMA2 HMCN2	5.23e-06	4	33	2	34504132
Pubmed	Endothelin-1 cooperates with hypoxia to induce vascular-like structures through vascular endothelial growth factor-C, -D and -A in lymphatic endothelial cells.	VEGFC VEGFD	5.23e-06	4	33	2	22552325
Pubmed	Differential expression of C-protein isoforms in developing and degenerating mouse striated muscles.	LAMA2 MYBPC3	8.72e-06	5	33	2	10024132
Pubmed	COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer.	VEGFC VEGFD	8.72e-06	5	33	2	16570043
Pubmed	Genetic blockade of lymphangiogenesis does not impair cardiac function after myocardial infarction.	VEGFC VEGFD	8.72e-06	5	33	2	34403369
Pubmed	VEGF-C is required for intestinal lymphatic vessel maintenance and lipid absorption.	VEGFC VEGFD	8.72e-06	5	33	2	26459520
Pubmed	Measurement of circulating levels of VEGF-A, -C, and -D and their receptors, VEGFR-1 and -2 in gastric adenocarcinoma.	VEGFC VEGFD	8.72e-06	5	33	2	18609713
Pubmed	VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling.	VEGFC VEGFD	1.31e-05	6	33	2	21909098
Pubmed	Celsr1 and Celsr2 exhibit distinct adhesive interactions and contributions to planar cell polarity.	CELSR1 CELSR2	1.31e-05	6	33	2	36712970
Pubmed	The Schlemm's canal is a VEGF-C/VEGFR-3-responsive lymphatic-like vessel.	VEGFC VEGFD	1.31e-05	6	33	2	25061878
Pubmed	Deletion of vascular endothelial growth factor C (VEGF-C) and VEGF-D is not equivalent to VEGF receptor 3 deletion in mouse embryos.	VEGFC VEGFD	1.83e-05	7	33	2	18519586
Pubmed	Early embryonic expression patterns of the mouse Flamingo and Prickle orthologues.	CELSR1 CELSR2	1.83e-05	7	33	2	17937400
Pubmed	CYR61 (CCN1) is essential for placental development and vascular integrity.	VEGFC TEK	1.83e-05	7	33	2	12446788
Pubmed	Transgenic mouse models in angiogenesis and cardiovascular disease.	VEGFC VEGFD	1.83e-05	7	33	2	10685072
Pubmed	Wnt signaling in midbrain dopaminergic neuron development and regenerative medicine for Parkinson's disease.	CELSR1 CELSR2 WIF1	3.12e-05	64	33	3	24431302
Pubmed	Vascular endothelial growth factor A (VEGF-A) is involved in guidance of VEGF receptor-positive cells to the anterior portion of early embryos.	VEGFC VEGFD	3.13e-05	9	33	2	15601856
Pubmed	Proteolytic activation defines distinct lymphangiogenic mechanisms for VEGFC and VEGFD.	VEGFC VEGFD	3.13e-05	9	33	2	27159393
Pubmed	VEGF-C is a trophic factor for neural progenitors in the vertebrate embryonic brain.	VEGFC VEGFD	4.78e-05	11	33	2	16462734
Pubmed	A dual role for planar cell polarity genes in ciliated cells.	CELSR1 CELSR2	4.78e-05	11	33	2	25024228
Pubmed	Differential expression of the seven-pass transmembrane cadherin genes Celsr1-3 and distribution of the Celsr2 protein during mouse development.	CELSR1 CELSR2	5.73e-05	12	33	2	11891983
Pubmed	Atypical cadherins Celsr1-3 differentially regulate migration of facial branchiomotor neurons in mice.	CELSR1 CELSR2	5.73e-05	12	33	2	20631168
Pubmed	A mutation in the tuft mouse disrupts TET1 activity and alters the expression of genes that are crucial for neural tube closure.	CELSR1 CELSR2	6.77e-05	13	33	2	26989192
Pubmed	Mesenchymal Vangl1 and Vangl2 facilitate airway elongation and widening independently of the planar cell polarity complex.	CELSR1 CELSR2	7.89e-05	14	33	2	39225402
Pubmed	Tbx18 regulates development of the epicardium and coronary vessels.	VEGFC VEGFD	7.89e-05	14	33	2	24016759
Pubmed	Angiogenic factors stimulate tubular branching morphogenesis of sonic hedgehog-deficient lungs.	VEGFC TEK	1.04e-04	16	33	2	17187775
Pubmed	Wnt2 signaling is necessary and sufficient to activate the airway smooth muscle program in the lung by regulating myocardin/Mrtf-B and Fgf10 expression.	VEGFC VEGFD	1.18e-04	17	33	2	21704027
Pubmed	Fibroblast growth factor signals regulate a wave of Hedgehog activation that is essential for coronary vascular development.	VEGFC VEGFD	1.18e-04	17	33	2	16778080
Pubmed	Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis.	VEGFC TEK	1.18e-04	17	33	2	10428027
Pubmed	Regulation of developmental lymphangiogenesis by Syk(+) leukocytes.	VEGFC VEGFD	1.32e-04	18	33	2	20230750
Interaction	MTUS2 interactions	ZBTB47 ZNF76 ZNF580 BCL6 ZNF564 ZNF785 ZNF774 ZNF764	8.57e-08	370	32	8	int:MTUS2
Interaction	CCDC136 interactions	ZBTB47 ZNF580 ZNF564 ZNF785 ZNF774	6.55e-06	169	32	5	int:CCDC136
Interaction	CMA1 interactions	CELSR1 CELSR2 VWDE	5.27e-05	46	32	3	int:CMA1
Interaction	SSX6P interactions	CELSR1 CELSR2	6.80e-05	8	32	2	int:SSX6P
Cytoband	16p11.2	ZNF747 ZNF768 ZNF785 ZNF764	1.08e-05	191	33	4	16p11.2
Cytoband	Ensembl 112 genes in cytogenetic band chr16p11	ZNF747 ZNF768 ZNF785 ZNF764	4.69e-05	278	33	4	chr16p11
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ATMIN ZNF747 ZBTB47 ZBTB8A ZNF76 ZNF580 BCL6 ZNF564 ZNF768 ZNF785 ZNF774 ZNF764	8.13e-11	718	26	12	28
GeneFamily	Adhesion G protein-coupled receptors, subfamily C\|CELSR cadherins	CELSR1 CELSR2	5.96e-06	3	26	2	913
GeneFamily	Adhesion G protein-coupled receptors, subfamily C\|CELSR cadherins	CELSR1 CELSR2	5.96e-06	3	26	2	1189
GeneFamily	VEGF family	VEGFC VEGFD	1.98e-05	5	26	2	1267
GeneFamily	Basic leucine zipper proteins\|BTB domain containing	ZBTB47 ZBTB8A BCL6	9.14e-04	134	26	3	861
GeneFamily	Fibronectin type III domain containing	TEK MYBPC3	2.20e-02	160	26	2	555
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	HMCN2 MYBPC3	2.23e-02	161	26	2	593
GeneFamily	Immunoglobulin like domain containing	HMCN2 TEK	3.11e-02	193	26	2	594
Coexpression	NABA_MATRISOME	VEGFC ADAMTS10 LAMA2 HMCN2 VEGFD SSPOP VWDE MEGF11 NTN3 WIF1	2.80e-07	1008	33	10	MM17056
Coexpression	NABA_MATRISOME	VEGFC ADAMTS10 LAMA2 HMCN2 VEGFD SSPOP VWDE MEGF11 NTN3 WIF1	3.29e-07	1026	33	10	M5889
Coexpression	NABA_ECM_GLYCOPROTEINS	LAMA2 HMCN2 SSPOP VWDE NTN3	3.92e-06	191	33	5	MM17059
Coexpression	NABA_ECM_GLYCOPROTEINS	LAMA2 HMCN2 SSPOP VWDE NTN3	4.45e-06	196	33	5	M3008
Coexpression	NABA_CORE_MATRISOME	LAMA2 HMCN2 SSPOP VWDE NTN3	2.09e-05	270	33	5	MM17057
Coexpression	NABA_CORE_MATRISOME	LAMA2 HMCN2 SSPOP VWDE NTN3	2.29e-05	275	33	5	M5884
Coexpression	GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_DN	ZNF76 TNFRSF25 DMRTA1 BCL6	1.11e-04	199	33	4	M3583
Coexpression	GSE3982_BASOPHIL_VS_TH2_UP	CELSR1 FCGBP BCL6 WIF1	1.13e-04	200	33	4	M5566
Coexpression	HEVNER_SUBVENTRICULAR_ZONE_AND_UP_PROJECTION_NEURON_FATE_COMMITTED_CELLS	BCL6 CELSR2	1.39e-04	14	33	2	MM417
Coexpression	DELYS_THYROID_CANCER_DN	LAMA2 FCGBP TEK SSPOP	2.03e-04	233	33	4	M13273
ToppCell	Healthy_donor-B_cell\|World / disease group, cell group and cell class (v2)	VEGFC LAMA2 CELSR1 ZNF768 ZNF785	8.48e-08	150	33	5	a2dfed562de7f58f902b547acec5a13853c80c4c
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	TNFRSF25 ZNF564 ZNF774 ZNF764 WIF1	1.41e-07	166	33	5	89e2b8453180983533faccb4275867861876d7ee
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6\|TCGA-Breast / Sample_Type by Project: Shred V9	ADAMTS10 LAMA2 ZBTB47 HMCN2 SCARF2	2.61e-07	188	33	5	c90669b51e1902fe7726555290c91c92a911df83
ToppCell	Healthy_donor-B_cell\|Healthy_donor / disease group, cell group and cell class (v2)	VEGFC LAMA2 ZNF768 ZNF785	4.75e-06	152	33	4	5768edfde8010324d8594815e73bbfba2c3045f3
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	TNFRSF25 ZNF564 ZNF774 WIF1	6.11e-06	162	33	4	2259e9536147e9cdee772e3a30ba7d104573262c
ToppCell	PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	FCGBP VWDE MEGF11 WIF1	1.05e-05	186	33	4	bb0bfe9a015151be08a6ffc5d82896d0556d76de
ToppCell	TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-3\|TCGA-Stomach / Sample_Type by Project: Shred V9	VEGFC LAMA2 TEK SCARF2	1.24e-05	194	33	4	2260cd817a6661e5eb6645b0c6786e18fd58371e
ToppCell	Tracheal-10x3prime_v2-Stromal-Mesofibroblastic\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	ADAMTS10 BCL6 MEGF11 WIF1	1.32e-05	197	33	4	d7cef7881abd807a679432766ced609a6efd1067
ToppCell	Tracheal-10x3prime_v2-Stromal-Mesofibroblastic-Mesothelia\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	ADAMTS10 BCL6 MEGF11 WIF1	1.32e-05	197	33	4	20a5958512bdb99daeb8f4d244df53e4f048f879
ToppCell	Skin-Fibroblasts\|Skin / Skin and Kidney Cells in Lupus Nephritis Patients.	ADAMTS10 LAMA2 SCARF2 WIF1	1.40e-05	200	33	4	f777eadf571a1a6d246da87346a9cb9d511c2e81
ToppCell	droplet-Trachea-nan-3m-Mesenchymal-mesenchymal_cell\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA2 SCARF2 WIF1	1.10e-04	126	33	3	c3261ea8726400de87f1c8a5a5134ba2b2884f66
ToppCell	TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-6\|TCGA-Lung / Sample_Type by Project: Shred V9	HMCN2 VEGFD MYBPC3	1.10e-04	126	33	3	b49b15ba1458488f98d54e87100257a12ee34076
ToppCell	LPS-IL1RA-Epithelial_alveolar-Mes-Like-AT1-AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HMCN2 ARSL WIF1	1.15e-04	128	33	3	082b3dc312b033c9b21cf73499009a1dc049ee2b
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gabrg1\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	BCL6 HMCN2 WIF1	1.50e-04	140	33	3	2c44e8cc5190226049be7ebc465d685393e701c4
ToppCell	Cerebellum\|World / BrainAtlas - Mouse McCarroll V32	VWDE MEGF11 MYBPC3	1.74e-04	147	33	3	dd730224e39571ca2c35042e242a908a02ee377d
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_B\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	LAMA2 ZBTB8A CELSR1	1.77e-04	148	33	3	1d9fa6b2ee9feaed39c63d44e638b5c0942d947c
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_B\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	LAMA2 ZBTB8A CELSR1	1.84e-04	150	33	3	98fdc6bdfde84d680e11d8727502b79afbf64303
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	VEGFC ZNF580 TEK	1.84e-04	150	33	3	322aa0c3fc159a4b2897daac881dfc744b24ffc4
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_D2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	TPBGL SCARF2 WIF1	1.91e-04	152	33	3	595afcfa8b161e291fcaf2afc7336bac9b6fae0f
ToppCell	mild_COVID-19_(asymptomatic)-CD8+_T_naive\|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)	TNFRSF25 DMRTA1 CELSR2	2.03e-04	155	33	3	e2c901d5c9e42d25d7702e5e8fc19b06f7c817be
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_D2\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	TPBGL SCARF2 WIF1	2.03e-04	155	33	3	216a240bfb82cdefc59e2f342689dbaaacb7c184
ToppCell	Fetal_29-31_weeks-Immune-mast_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	TNFRSF25 ZNF580 CRB2	2.15e-04	158	33	3	0c27c475289c70b17b6a66fc71f628511c5f0ae1
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage\|356C / Donor, Lineage, Cell class and subclass (all cells)	ZNF564 ZNF774 ZNF764	2.19e-04	159	33	3	24f87c666eff10c1844c900ffd7ad49fa9f80481
ToppCell	facs-Marrow-Granulocytes-3m-Lymphocytic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA2 VEGFD WIF1	2.23e-04	160	33	3	8590281165eab6514a9f6a022b900d4c222c1044
ToppCell	severe_influenza-cDC\|severe_influenza / disease group, cell group and cell class (v2)	ZBTB8A DMRTA1 ARSL	2.27e-04	161	33	3	7716315b8bda904b346cea47edc2c0b507a345c2
ToppCell	facs-Kidney-nan-24m-Mesenchymal-mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SCARF2 CRB2 WIF1	2.44e-04	165	33	3	c746bb22ef52d7f7fa6ee9c37ae6bbe0ccce718e
ToppCell	facs-Kidney-nan-24m-Mesenchymal-mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SCARF2 CRB2 WIF1	2.44e-04	165	33	3	4cdd80580d5638fd649280ba3893251c2f898f3f
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	VEGFC HMCN2 TEK	2.44e-04	165	33	3	a74751e0ec857aa974bec04ccc747c004a8f6e01
ToppCell	Adult-Epithelial-lung_goblet_cell-D122\|Adult / Lineage, Cell type, age group and donor	ADAMTS10 CELSR1 FCGBP	2.52e-04	167	33	3	6efbb2ef6adc8da5dd67210969f825f5cc8ed022
ToppCell	PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	CELSR1 WIF1 MYBPC3	2.52e-04	167	33	3	25af48c640e67848594f5902867ba325fc105da4
ToppCell	droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	LAMA2 TPBGL SCARF2	2.57e-04	168	33	3	d2b91f2adc95dcfa623f8d7ca2df1c6f884da988
ToppCell	Adult-Mesenchymal-chondrocyte-D175\|Adult / Lineage, Cell type, age group and donor	VEGFC LAMA2 HMCN2	2.57e-04	168	33	3	14071b961c9bdb54a8259b12a88237b802cbde36
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	VEGFC HMCN2 TEK	2.61e-04	169	33	3	c7fc3a8c44f07c557b60d469717b66e2f5863d38
ToppCell	COVID-19-Heart-CM_+_Macrophage\|Heart / Disease (COVID-19 only), tissue and cell type	FCGBP ZNF774 MYBPC3	2.66e-04	170	33	3	4232fe937909f93d3736988c707b8f95ce993398
ToppCell	E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Uncommitted_AE_cell\|E16.5-samps / Age Group, Lineage, Cell class and subclass	CELSR1 FCGBP CELSR2	2.66e-04	170	33	3	5a64e05c263df915085988d881808221e2c0f2e2
ToppCell	droplet-Kidney-nan-3m-Epithelial-Pecam____kidney_capillary_endothelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SCARF2 CRB2 WIF1	2.75e-04	172	33	3	073a503dc922e3e3ac3528e249b0f8b74402110b
ToppCell	normal_Lung-T/NK_cells-Exhausted_Tfh\|normal_Lung / Location, Cell class and cell subclass	TNFRSF25 MEGF11 ZNF764	2.80e-04	173	33	3	e8ead6c51c41dbd43c717ba9d1a7a0ab39c79330
ToppCell	facs-Lung-18m-Hematologic-lymphocytic-immature_innate_lymphoid_cell-Ly6g5b+_T\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TNFRSF25 DMRTA1 TPBGL	2.80e-04	173	33	3	0a355386210a13927ea29b10b64cb059459952d4
ToppCell	facs-Lung-18m-Hematologic-lymphocytic-immature_innate_lymphoid_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TNFRSF25 DMRTA1 TPBGL	2.80e-04	173	33	3	3678b300cad4effd7f49bfb043305ed512693848
ToppCell	facs-Lung-EPCAM-18m-Lymphocytic-Ly6g5b+_T\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNFRSF25 DMRTA1 TPBGL	2.85e-04	174	33	3	d9489c4196d103ead8cb6279492bbe563a222e45
ToppCell	5'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-ILCP\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ZNF747 TNFRSF25 CELSR1	2.85e-04	174	33	3	c0204a0d0a979a489e8d30dc5396e99da14c119c
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MEGF11 NTN3 WIF1	2.85e-04	174	33	3	c529f3674b784f872f4387ffdeb46aecb619976b
ToppCell	facs-Lung-EPCAM-18m-Lymphocytic-T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNFRSF25 DMRTA1 TPBGL	2.85e-04	174	33	3	aae7ab9df5a78716034ddfd5bd47adc69912d624
ToppCell	normal_Lung-T/NK_cells-Exhausted_Tfh\|T/NK_cells / Location, Cell class and cell subclass	TNFRSF25 MEGF11 ZNF764	2.85e-04	174	33	3	e324320b52c904496e26fcecfa179b3431729ec0
ToppCell	severe_COVID-19-HSPC\|severe_COVID-19 / disease group, cell group and cell class (v2)	ZBTB8A ARSL VWDE	2.85e-04	174	33	3	6d35bacf073537b272ff821e604c899fb9ce6a7c
ToppCell	facs-Skin-nan-24m-Epithelial-basal_cell_of_epidermis\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CELSR1 FCGBP VEGFD	2.90e-04	175	33	3	21542be95059983d2c8bdf01ec711fdbf1ec1f62
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LAMA2 HMCN2 VEGFD	2.99e-04	177	33	3	bd602db857f37869ef76d14c05ef522c509f08ee
ToppCell	severe_COVID-19-HSPC\|World / disease group, cell group and cell class (v2)	ZBTB8A ARSL VWDE	2.99e-04	177	33	3	289f6aed6f054b04b01659434d8c8b467d1bf5dd
ToppCell	10x3'2.3-week_17-19-Lymphocytic_T-T_NK-NK_T_cell\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	ADAMTS10 TNFRSF25 CELSR1	3.04e-04	178	33	3	a34bb693b72684cbd97ac9efff77d2d14e41be75
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LAMA2 TPBGL SCARF2	3.04e-04	178	33	3	78a0c6340001a77f5b2d890b6263f574af2e72da
ToppCell	facs-Marrow-Granulocytes-3m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA2 VEGFD WIF1	3.04e-04	178	33	3	6d9ecfaeb50d562899380de379ebf7b99fd8adc9
ToppCell	facs-Marrow-Granulocytes-3m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA2 VEGFD WIF1	3.04e-04	178	33	3	d3f518cd75b02e85d45cbb9b2eff30f0272512a8
ToppCell	-Donor_06\|World / lung cells shred on cell class, cell subclass, sample id	LAMA2 TNFRSF25 VEGFD	3.09e-04	179	33	3	e4224b2e9c4ae7da62cf670adf811f4112c7d060
ToppCell	metastatic_Brain-Myeloid_cells-CD207+CD1a+_LCs\|metastatic_Brain / Location, Cell class and cell subclass	TPBGL FCGBP MYBPC3	3.15e-04	180	33	3	51727cb66fe7a7709453f7026e0ff3d6c93d5aa5
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	VEGFC LAMA2 VEGFD	3.20e-04	181	33	3	9ede19228ba5c0668a9c06c915510b95585216ef
ToppCell	5'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VEGFC SSPOP WIF1	3.25e-04	182	33	3	52274af3136d4fd4a495f5882618444661421f0f
ToppCell	5'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VEGFC SSPOP WIF1	3.25e-04	182	33	3	dfde2d9950f445c6c936ac828f7210de87bb45ec
ToppCell	facs-Skin-Anagen-3m-Epithelial-Basal_IFE\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CELSR1 FCGBP VEGFD	3.25e-04	182	33	3	22d6f4790950508e8aa27e02a8133af5f53f13c8
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	BCL6 HMCN2 WIF1	3.30e-04	183	33	3	5a541a7f6c3514be8a13e988185dfe388c874f8b
ToppCell	droplet-Kidney-nan-21m-Epithelial-Pecam____kidney_capillary_endothelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SCARF2 CRB2 WIF1	3.30e-04	183	33	3	f55081068213cc1cdb2acad58ff10f6b48b44c72
ToppCell	droplet-Kidney-nan-21m-Mesenchymal-fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA2 VEGFD SCARF2	3.35e-04	184	33	3	3bffadb0cb2e0d825bdb6cfc5d23f5436cbc3efd
ToppCell	COVID-19-Endothelial_cells-Arterial_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	VEGFC HMCN2 TEK	3.35e-04	184	33	3	0f19494789f38ab1a420545e15e748ca7eb345c3
ToppCell	droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____kidney_capillary_endothelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SCARF2 CRB2 WIF1	3.35e-04	184	33	3	1c857126c0ea0671f0d60b048efca288d348d653
ToppCell	droplet-Kidney-nan-21m-Mesenchymal-Stroma____fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA2 VEGFD SCARF2	3.41e-04	185	33	3	9954fc85b183c1cc45c3c24e3dadc7984ee6f649
ToppCell	facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal-stromal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA2 TEK VEGFD	3.41e-04	185	33	3	3cd0686a14e734a0f243070ab939adcb4c454478
ToppCell	droplet-Kidney-nan-21m-Mesenchymal\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA2 VEGFD SCARF2	3.41e-04	185	33	3	33cc0e9d8b54cb7408b51235f2a70e044ebae04d
ToppCell	facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal-stromal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA2 TEK VEGFD	3.41e-04	185	33	3	00258f458cbf6d36449db95528a6b5038d731d2d
ToppCell	facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA2 TEK VEGFD	3.41e-04	185	33	3	a94694e226856bc5b168464f52d76004145717a5
ToppCell	wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CELSR1 ARSL ZNF785	3.41e-04	185	33	3	636505a3d96f75d951ab42bcf8af6ae07abc732d
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell-D231\|Adult / Lineage, Cell type, age group and donor	ADAMTS10 LAMA2 HMCN2	3.41e-04	185	33	3	fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804
ToppCell	droplet-Lung-LUNG-30m-Mesenchymal-Alveolar_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA2 VEGFD SCARF2	3.46e-04	186	33	3	ca5e9c6531cb5d199e27509bfab1d62e3937177e
ToppCell	droplet-Lung-LUNG-30m-Mesenchymal-fibroblast_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA2 VEGFD SCARF2	3.46e-04	186	33	3	1ed71b229f40a680071b14f5a7a19706e0fd14b1
ToppCell	E16.5-samps-Mesenchymal-Myofibroblast\|E16.5-samps / Age Group, Lineage, Cell class and subclass	ADAMTS10 LAMA2 WIF1	3.46e-04	186	33	3	e044b3428b7eacfdc72d0f57cdabaa1de04c74cd
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D175\|Adult / Lineage, Cell type, age group and donor	VEGFC LAMA2 SCARF2	3.52e-04	187	33	3	e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f
ToppCell	droplet-Lung-LUNG-30m-Mesenchymal\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA2 VEGFD SCARF2	3.52e-04	187	33	3	976b74d081b7fba8620768613cc26f9262cd7b16
ToppCell	P15-Mesenchymal\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	LAMA2 VEGFD SCARF2	3.57e-04	188	33	3	f1ba0b661621a65c91432e62ba73531bdf18e7c1
ToppCell	Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Pvrl3-Excitatory_Neuron.Slc17a7.Pvrl3-Grm5_(CA3_Principal_cells)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	FCGBP MYBPC3	3.61e-04	38	33	2	b76689fb0e0845e0e42e332b3dca02bc0ad241b9
ToppCell	facs-Lung-18m-Mesenchymal-fibroblast\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	LAMA2 VEGFD SCARF2	3.63e-04	189	33	3	40cbd679dc0548bf5207e1b033c0597886ad6fe1
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	VEGFC HMCN2 TEK	3.63e-04	189	33	3	6463890d8dbee4bc198f91628a5f784970de786a
ToppCell	3'-Airway_Nasal_SMG-Epithelial\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DMRTA1 FCGBP MYBPC3	3.63e-04	189	33	3	a174f5757a53a68a753111a204efc1bb6da80d8b
ToppCell	3'-Airway_Nasal_SMG\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DMRTA1 FCGBP MYBPC3	3.63e-04	189	33	3	bb2b626645e9f060f0d99d05d1ea651fd8bc4945
ToppCell	3'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DMRTA1 FCGBP MYBPC3	3.63e-04	189	33	3	24741fe93438c1031fc5caa8837ef82d8d23f099
ToppCell	facs-Trachea-24m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_trachea\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CELSR1 FCGBP CELSR2	3.63e-04	189	33	3	ee15b4fb3a1cfda80bcf210a23f04f242594015e
ToppCell	droplet-Lung-immune-endo-depleted\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA2 VEGFD SCARF2	3.63e-04	189	33	3	c3fb363bb0156ffb3367c200f548faebda64ab4a
ToppCell	facs-Trachea-24m-Epithelial-airway_epithelial-respiratory_basal_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CELSR1 FCGBP CELSR2	3.63e-04	189	33	3	dc6f6fae84347d145bea71b49eaeeb3028e9c4ae
ToppCell	facs-Lung-18m-Mesenchymal\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	LAMA2 VEGFD SCARF2	3.63e-04	189	33	3	bdf8db938aa0863c4fed6fa99dcffd63c8c20c31
ToppCell	droplet-Lung-immune-endo-depleted-3m\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA2 VEGFD SCARF2	3.63e-04	189	33	3	2a2953f6b1b7d070d739dcaf7285fce6e097d9e4
ToppCell	droplet-Lung-3m\|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	LAMA2 VEGFD SCARF2	3.63e-04	189	33	3	5a636e952da9b1fd26aa17f7b129054f2da322b5
ToppCell	droplet-Lung-18m-Mesenchymal-fibroblast\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	LAMA2 VEGFD SCARF2	3.63e-04	189	33	3	e76dc36a01d8ad7590b3acc4c46abfcb76857448
ToppCell	droplet-Lung-immune-endo-depleted-3m-Mesenchymal\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA2 VEGFD SCARF2	3.68e-04	190	33	3	9cd147a174017ebda23cc47b6d4552d898acd092
ToppCell	droplet-Lung-18m-Mesenchymal\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	LAMA2 VEGFD SCARF2	3.68e-04	190	33	3	0b7200897b2c389632c9b1ee37e272b811555dbc
ToppCell	droplet-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	LAMA2 VEGFD SCARF2	3.74e-04	191	33	3	36467322096bc766cd777dae3bfb4e65511e492c
ToppCell	RV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	LAMA2 BCL6 VEGFD	3.74e-04	191	33	3	70c067c54084bfb02c29bab085f4defd477194fb
ToppCell	facs-Lung-24m-Mesenchymal-fibroblast\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	LAMA2 VEGFD SCARF2	3.74e-04	191	33	3	094c9d3270fc1e487ccf10fb4936af5f081f6009
ToppCell	droplet-Lung-21m-Mesenchymal-fibroblast\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	LAMA2 VEGFD SCARF2	3.74e-04	191	33	3	8a73d2df079566fca4cbb5cdb85721c2e87134c8
ToppCell	droplet-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	LAMA2 VEGFD SCARF2	3.74e-04	191	33	3	94795daf05061baa3b72a1b01c9e940af86de044
ToppCell	droplet-Lung-30m-Mesenchymal-fibroblast\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	LAMA2 VEGFD SCARF2	3.74e-04	191	33	3	cd497abed9e00e4e0becd9dbc036c6e7a60ae791
ToppCell	droplet-Lung-1m-Mesenchymal-fibroblast\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	LAMA2 VEGFD SCARF2	3.74e-04	191	33	3	ce80f65bd24b1c4d2152bf45248449e7a1a97e56
ToppCell	facs-Skin\|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CELSR1 FCGBP BCL6	3.74e-04	191	33	3	ae524103331fa53fa82888dbb567fc36abcee7e0
ToppCell	droplet-Lung-21m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	LAMA2 VEGFD SCARF2	3.74e-04	191	33	3	c715bbdbbf1482aad45a50a16d5232fd35a9a0bb
Computational	Genes in the cancer module 178.	VEGFC VEGFD	3.55e-04	17	18	2	MODULE_178
Computational	Angiogenesis.	VEGFC VEGFD	5.46e-04	21	18	2	MODULE_362
Disease	Milroy Disease	VEGFC CELSR1	1.07e-05	5	31	2	C1704423
Disease	left ventricular mass	ADAMTS10 MYBPC3	1.62e-04	18	31	2	EFO_0009289
Disease	Hemangiosarcoma	VEGFC TEK	1.62e-04	18	31	2	C0018923
Disease	urinary bladder cancer (is_marker_for)	VEGFC VEGFD WIF1	1.94e-04	107	31	3	DOID:11054 (is_marker_for)
Disease	nephroblastoma (is_marker_for)	VEGFC WIF1	5.87e-04	34	31	2	DOID:2154 (is_marker_for)
Disease	left ventricular mass index	ADAMTS10 MYBPC3	5.87e-04	34	31	2	EFO_0009290
Disease	lymphoid leukemia	CELSR1 MEGF11	7.33e-04	38	31	2	EFO_0004289
Disease	invasive ductal carcinoma (is_marker_for)	VEGFC WIF1	8.13e-04	40	31	2	DOID:3008 (is_marker_for)
Disease	response to trauma exposure	DMRTA1 WIF1	1.32e-03	51	31	2	EFO_0008483
Disease	cholesterol to total lipids in large LDL percentage	CELSR2 MYBPC3	1.59e-03	56	31	2	EFO_0022235
Disease	multiple sclerosis	TNFRSF25 DMRTA1 BCL6 MYBPC3	3.32e-03	594	31	4	MONDO_0005301
Disease	Hodgkins lymphoma	FCGBP MEGF11	3.37e-03	82	31	2	EFO_0000183

Protein segments in the cluster

Peptide	Gene	Start	Entry
PEGAGACYGRKVCPC	ARSL	486	P51690
GLRCRCPPGFTGDYC	CELSR1	1346	Q9NYQ6
GLRCRCPPGFTGDYC	CELSR2	1271	Q9HCU4
CYKRVCVPFGSRPEG	ADAMTS10	531	Q9H324
GACECEPGYKGPRCQ	MEGF11	331	A6BM72
EPGYKGPRCQERLCP	MEGF11	336	A6BM72
GFRCYCVPGFQGPRC	CRB2	91	Q5IJ48
FECRCPPGFGGPRCR	CRB2	1116	Q5IJ48
GSYRCLPDCGPGFRV	HMCN2	4691	Q8NDA2
GPRCERCAEGYFGQP	LAMA2	841	P24043
EGPDCGRCKPFYCDR	NTN3	281	O00634
TGPKFYCCPIEGCPR	ATMIN	126	O43313
YPGPGCDSLCRCREG	FCGBP	2406	Q9Y6R7
FYPGPGCDSLCRCRE	FCGBP	3606	Q9Y6R7
VFYPGPECERRCECG	FCGBP	4806	Q9Y6R7
AVGCGYPRTPKCARC	DMRTA1	86	Q5VZB9
GEKPYPCEICGTRFR	BCL6	626	P41182
GRLYRECQPGEGCPF	SSPOP	3701	A2VEC9
GPYKCQVCGRAFDCP	ZNF564	391	Q8TBZ8
PKCLYGGRCIFPNVC	VWDE	1556	Q8N2E2
FFKPPCVSVYRCGGC	VEGFC	151	P49767
GERPYPCQACGKRFS	ZBTB8A	306	Q96BR9
EPCPAGFYGLGCRRR	SCARF2	271	Q96GP6
LGDRPYRCPECGKTF	ZNF774	426	Q6NX45
GEKPYRCPQCGRCFG	ZNF747	261	Q9BV97
GERPYRCAVCGKGFC	ZNF768	481	Q9H5H4
CFYPGKCICPPGLEG	WIF1	256	Q9Y5W5
ACHPGFYGPDCKLRC	TEK	301	Q02763
FCCRGCPAGHYLKAP	TNFRSF25	46	Q93038
GEKPYPCDVCGQRFR	ZBTB47	656	Q9UFB7
PCPFQCYCFGGPKLL	TPBGL	26	P0DKB5
FFKPPCVNVFRCGGC	VEGFD	131	O43915
PGPRKGYSCPECARV	ZNF580	86	Q9UK33
GDRPYRCDFPSCGKA	ZNF76	191	P36508
HTGEKPYPCPDCGRR	ZNF785	306	A8K8V0
GEKPYPCPDCGRCFR	ZNF764	311	Q96H86
RKPCPFDGGIYVCRA	MYBPC3	1241	Q14896